87 related articles for article (PubMed ID: 8906343)
1. Indole derivatives as probes to study the benzodiazepine binding site in GABA receptor complex.
Da Settimo A; Primofiore G; Da Settimo F; Novellino E; Greco G; Martini C; Senatore G; Lucacehini A
Adv Exp Med Biol; 1996; 398():677-83. PubMed ID: 8906343
[No Abstract] [Full Text] [Related]
2. Saturation assays of radioligand binding to receptors and their allosteric modulatory sites.
Basile A
Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.6. PubMed ID: 18428532
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of ammonia on the benzodiazepine modulatory site on the GABA-A receptor complex of human brain.
Ahboucha S; Araqi F; Layrargues GP; Butterworth RF
Neurochem Int; 2005 Jul; 47(1-2):58-63. PubMed ID: 15913842
[TBL] [Abstract][Full Text] [Related]
4. Solubilized benzodiazepine receptors for use in receptor assays.
Janssen MJ; Stegeman M; Ensing K; de Zeeuw RA
J Pharm Biomed Anal; 1996 Jun; 14(8-10):989-96. PubMed ID: 8818005
[TBL] [Abstract][Full Text] [Related]
5. New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluation.
Taliani S; Simorini F; Sergianni V; La Motta C; Da Settimo F; Cosimelli B; Abignente E; Greco G; Novellino E; Rossi L; Gremigni V; Spinetti F; Chelli B; Martini C
J Med Chem; 2007 Jan; 50(2):404-7. PubMed ID: 17228885
[TBL] [Abstract][Full Text] [Related]
6. N'-Phenylindol-3-ylglyoxylohydrazide derivatives: synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors.
Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Gesi M; Martini C; Giannaccini G; Lucacchini A
J Med Chem; 1998 Sep; 41(20):3821-30. PubMed ID: 9748357
[TBL] [Abstract][Full Text] [Related]
7. In vivo labelling of alpha5 subunit-containing GABA(A) receptors using the selective radioligand [(3)H]L-655,708.
Atack JR; Alder L; Cook SM; Smith AJ; McKernan RM
Neuropharmacology; 2005 Aug; 49(2):220-9. PubMed ID: 15996568
[TBL] [Abstract][Full Text] [Related]
8. New insight into the central benzodiazepine receptor-ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds.
Anzini M; Valenti S; Braile C; Cappelli A; Vomero S; Alcaro S; Ortuso F; Marinelli L; Limongelli V; Novellino E; Betti L; Giannaccini G; Lucacchini A; Daniele S; Martini C; Ghelardini C; Di Cesare Mannelli L; Giorgi G; Mascia MP; Biggio G
J Med Chem; 2011 Aug; 54(16):5694-711. PubMed ID: 21751815
[TBL] [Abstract][Full Text] [Related]
9. Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.
Dean B; Scarr E; McLeod M
Brain Res Mol Brain Res; 2005 Aug; 138(2):145-55. PubMed ID: 15950312
[TBL] [Abstract][Full Text] [Related]
10. Allosteric uncoupling and up-regulation of benzodiazepine and GABA recognition sites following chronic diazepam treatment of HEK 293 cells stably transfected with alpha1beta2gamma2S subunits of GABA (A) receptors.
Pericić D; Strac DS; Jembrek MJ; Vlainić J
Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):177-87. PubMed ID: 17377772
[TBL] [Abstract][Full Text] [Related]
11. Geometrically constrained analogues of N-benzylindolylglyoxylylamides: [1, 2, 4]triazino[4, 3-a]benzimidazol-4(10H)-one derivatives as potential new ligands at the benzodiazepine receptor.
Primofiore G; Da Settimo F; Taliani S; Marini AM; Simorini F; Novellino E; Greco G; Trincavelli L; Martini C
Arch Pharm (Weinheim); 2003 Sep; 336(9):413-21. PubMed ID: 14528489
[TBL] [Abstract][Full Text] [Related]
12. Acute pentylenetetrazol injection reduces rat GABAA receptor mRNA levels and GABA stimulation of benzodiazepine binding with No effect on benzodiazepine binding site density.
Walsh LA; Li M; Zhao TJ; Chiu TH; Rosenberg HC
J Pharmacol Exp Ther; 1999 Jun; 289(3):1626-33. PubMed ID: 10336561
[TBL] [Abstract][Full Text] [Related]
13. N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor.
Primofiore G; Da Settimo F; Taliani S; Simorini F; Patrizi MP; Novellino E; Greco G; Abignente E; Costa B; Chelli B; Martini C
J Med Chem; 2004 Mar; 47(7):1852-5. PubMed ID: 15027878
[TBL] [Abstract][Full Text] [Related]
14. Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.
Benavides J; Peny B; Ruano D; Vitorica J; Scatton B
Brain Res; 1993 Feb; 604(1-2):240-50. PubMed ID: 8096157
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vivo and ex vivo [3H]flumazenil binding assays to determine occupancy at the benzodiazepine binding site of rat brain GABAA receptors.
Li J; Fish RL; Cook SM; Tattersall FD; Atack JR
Neuropharmacology; 2006 Jul; 51(1):168-72. PubMed ID: 16697018
[TBL] [Abstract][Full Text] [Related]
16. Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain.
McLeod MC; Sundram S; Dean B
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):560-7. PubMed ID: 18045761
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats.
Abe K; Kashiwagi Y; Tokumura M; Hosoi R; Hatazawa J; Inoue O
Synapse; 2004 Sep; 53(4):234-9. PubMed ID: 15266555
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor.
Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Martini C; Giannaccini G; Lucacchini A
J Med Chem; 1996 Dec; 39(26):5083-91. PubMed ID: 8978839
[TBL] [Abstract][Full Text] [Related]
19. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
[TBL] [Abstract][Full Text] [Related]
20. Chronic exposure of cells expressing recombinant GABAA receptors to benzodiazepine antagonist flumazenil enhances the maximum number of benzodiazepine binding sites.
Pericić D; Lazić J; Jembrek MJ; Strac DS; Rajcan I
Life Sci; 2004 Dec; 76(3):303-17. PubMed ID: 15531382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
